View ICR - OIRA Conclusion



0910-0230 200904-0910-004
Historical Active 200602-0910-006
HHS/FDA
Adverse Drug Experience Reporting
Extension without change of a currently approved collection   No
Regular
Approved with change 07/23/2009
Retrieve Notice of Action (NOA) 04/02/2009
This ICR is approved consistent with revised supporting statement. FDA is reminded to accurately categorize the burdens (reporting, recordkeeping, or third-party disclosure) and the costs (capital costs).
  Inventory as of this Action Requested Previously Approved
07/31/2012 36 Months From Approved 07/31/2009
411,509 0 410,645
7,089,086 0 7,037,246
46,962 0 1,416,000